Oura buys AI-powered primary care startup Counsel Health for $625 million
Oura announced Tuesday it is acquiring Counsel Health, an AI-driven primary care startup, for $625 million in cash. The deal will merge Counsel’s medical AI and team of doctors into Oura’s app, transforming it into a hub for preventive and chronic care. While Oura’s revenue nearly doubled in 2026, the company delayed its $2.2 billion IPO, citing shaky markets.
Editor, Lazyfounder

30 SEC SUMMARY
- Oura is paying $625 million in cash to buy Counsel Health, an AI-driven primary care startup.
- The acquisition brings 70 employees and a 24/7 medical AI system into Oura’s app, which already serves six million members.
- Revenue for Q3 2026 reached $533 million, a 153% jump year-over-year, while full-year sales hit $1.75 billion, up 92%.
- Oura pushed back its $2.2 billion IPO in September 2026, citing turbulent markets.
- On November 22, Oura Ring 5 arrives in 1,000 Ulta Beauty stores—the first health wearable the chain has ever carried.
TABLE OF CONTENTS
- Oura acquires Counsel Health for $625 million
- AI-driven care and physician access come to Oura’s app
- Revenue surges while IPO plans stall
- Oura Ring 5 debuts in Ulta Beauty stores amid legal challenges
- Oura defends its market lead with new features and legal battles
- What this means
- Key takeaways
- Sources
KEY HIGHLIGHTS
- Oura will buy Counsel Health for $625 million in cash; the deal is set to close by the end of 2027.
- Counsel Health’s 70 employees, including CEO Muthu Alagappan, will join Oura, with Alagappan taking the role of chief clinical AI officer.
- Oura’s Q3 2026 revenue surged 153% year-over-year to $533 million; full-year revenue reached $1.75 billion, up 92%.
- Oura postponed its up-to-$2.2 billion IPO in September 2026 due to market uncertainty.
- Oura Ring 5 will be sold in 1,000 Ulta Beauty stores starting November 22—the first health wearable the chain has ever stocked.
- A California class-action lawsuit claims Oura’s sleep-stage estimates are unreliable.
Oura acquires Counsel Health for $625 million
Finnish-founded Oura is buying Counsel Health, a California-based AI primary-care startup, for $625 million in cash. The deal will fold Counsel’s 70 employees—including its CEO, Muthu Alagappan—into Oura’s app, giving users access to around-the-clock medical AI and real doctors.
Oura expects to close the acquisition by the end of 2027. It’s the company’s third acquisition of 2026, following January’s purchase of Galen AI and April’s deal for Doublepoint AI.
AI-driven care and physician access come to Oura’s app
Counsel Health was built by doctors and AI researchers. Its system relies on specialized AI agents to gather medical histories, review records, and spot emergencies. Physicians then review the AI’s work and provide feedback, refining the system’s accuracy over time.
Since June, Oura’s six million members have had access to Counsel’s chat-based medical advice within the Oura app. A survey found that 90% of users who tried Counsel said their Oura Ring data helped them receive better care.
Oura plans to expand the partnership to cover preventive, acute, and chronic care. The integration will include reproductive health, aging, and cardiometabolic conditions. Counsel will continue serving its enterprise clients—health plans, health systems, and employers—while also supporting Oura’s user base.
Revenue surges while IPO plans stall
Oura’s revenue jumped 153% year-over-year to $533 million in the third quarter of 2026, according to unaudited figures. Full-year sales reached $1.75 billion, a 92% increase over 2025.
The growth followed a $900 million late-stage funding round in October 2025, which lifted Oura’s valuation to $11 billion. Still, the company postponed its planned $2.2 billion IPO in September 2026, citing volatile market conditions.
David Shuman, Oura’s executive chairman, called the acquisition a strategic shift beyond hardware. "Combining Oura’s data with Counsel’s clinical expertise expands our market and helps users act on their health insights," he said.
Oura Ring 5 debuts in Ulta Beauty stores amid legal challenges
Oura Ring 5 will hit shelves in 1,000 Ulta Beauty stores across the U.S. on November 22. The deal marks the first time the beauty retailer has stocked a health wearable, blending wellness tech with its traditional offerings.
The retail launch comes as Oura faces legal scrutiny. A class-action lawsuit filed in California alleges the company’s sleep-stage estimates are no more reliable than a coin flip. Oura maintains its ring is not a medical device and does not diagnose or treat illness.
Oura defends its market lead with new features and legal battles
Oura is fighting to keep its lead in the smart ring market. In March 2026, it sued Ultrahuman, accusing the Indian startup of infringing patents tied to its redesigned Ring Pro. A U.S. Customs ruling later allowed Ultrahuman’s rings back into the country, escalating competition.
To stay ahead, Oura added Cardio Effort and VO₂ Max metrics to its third-generation rings earlier this year. The updates bring its fitness-tracking capabilities closer to those of Apple Watch, Garmin, and Fitbit.
What this means
Lazyfounder analysis — our interpretation, not reported fact.
Oura is turning its smart ring into a gateway for AI-driven medical care, aiming to lock in recurring revenue while waiting for markets to stabilize before its IPO.
Key takeaways
- The $625 million Counsel Health deal links Oura’s ring data to real-time AI doctors and physicians, creating a new subscription service beyond hardware.
- Ulta Beauty’s decision to stock Oura Ring 5 shows health wearables are now mainstream in beauty retail.
- Counsel Health is Oura’s priciest acquisition—double the combined cost of its two earlier AI deals—signaling clinical integration is its top priority.
Related on Lazyfounder
Sources
- The Next Web · 2026-11-10
Oura buys Counsel Health for $625m to put AI and doctors in its app - TechCrunch · 2026-11-10
Oura to acquire AI-native primary care startup Counsel Health for $625M - ZDNET · 2026-11-11
Oura Ring users may get in-app access to real doctors soon – what we know
This story is an original summary drafted with AI by Lazyfounder from the reporting listed above and checked by automated validation. Facts are attributed to their original publishers; sections marked as analysis are Lazyfounder's. Where a source is in another language, facts were machine-translated and quotations are reported, not reproduced. Read the original coverage via the links, and see our AI policy and corrections policy.
About the author
Editor, Lazyfounder
Tarun Mottlia edits LazyFounders, covering Indian startups, funding rounds, AI and product launches. Every story on the site is AI-assisted and checked against its cited sources before publication.
More stories by Tarun MottliaGet the LazyFounder Brief
Startup, funding and AI news in a five-minute read. Join the early-access list.


